Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
2.830
+0.020 (0.71%)
Sep 19, 2024, 4:00 PM EDT - Market closed
Cyclerion Therapeutics Market Cap
Cyclerion Therapeutics has a market cap or net worth of $7.12 million as of September 19, 2024. Its market cap has decreased by -17.21% in one year.
Market Cap
7.12M
Enterprise Value
2.53M
1-Year Change
-17.21%
Ranking
Category
Stock Price
$2.83
Market Cap Chart
Since March 18, 2019, Cyclerion Therapeutics's market cap has decreased from $194.40M to $7.12M, a decrease of -96.34%. That is a compound annual growth rate of -45.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2024 | 7.60M | -7.32% |
| Dec 29, 2023 | 8.20M | -71.23% |
| Dec 30, 2022 | 28.50M | -61.74% |
| Dec 31, 2021 | 74.50M | -28.30% |
| Dec 31, 2020 | 103.90M | 39.09% |
| Dec 31, 2019 | 74.70M | -61.57% |
| Mar 18, 2019 | 194.40M | - |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intelligent Bio Solutions | 7.73M |
| Eterna Therapeutics | 7.63M |
| Kindly MD | 7.55M |
| Mangoceuticals | 7.39M |
| Hoth Therapeutics | 7.39M |
| Syra Health | 7.36M |
| Coeptis Therapeutics Holdings | 7.15M |
| Aptose Biosciences | 7.06M |